Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_provenance.
- NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_assertion description "[The antiproliferative effects of somatostatin and its analogs on human pancreatic cancers were studied: (1) by evaluating the gene expression of somatostatin receptor (sstr) subtypes in human pancreatic cancer cell lines and cancer tissue specimens, (2) by evaluating the antiproliferative effects of somatostatin analogs, and (3) by evaluating the effect of sstr-2 cDNA transduction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_provenance.
- NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_assertion evidence source_evidence_literature NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_provenance.
- NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_assertion SIO_000772 11180877 NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_provenance.
- NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_assertion wasDerivedFrom befree-20150227 NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_provenance.
- NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_assertion wasGeneratedBy ECO_0000203 NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_provenance.
- befree-20150227 importedOn "2015-02-27" NP714421.RA5hRxg-YhT8NIE3Co2JL2EwMEIE6vXMhfqLUoxKpflEs130_provenance.